Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
94
KLG Quote, Financials, Valuation and Earnings
Last price:
$23.54
Seasonality move
:
4.83%
Day range:
$23.02 - $23.18
52-week range:
$14.80 - $23.18
Dividend yield:
2.8%
P/E ratio:
36.22x
P/S ratio:
0.76x
P/B ratio:
6.11x
Volume:
1.7M
Avg. volume:
2.8M
1-year change:
41.26%
Market cap:
$2B
Revenue:
$2.7B
EPS (TTM):
$0.64
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $2.5B | $2.7B | $2.8B | $2.7B | |
| Revenue Growth (YoY) | -- | -14.2% | 9.55% | 2.52% | -1.99% | |
| Cost of Revenues | $2B | $1.9B | $2.1B | $2B | $1.9B | |
| Gross Profit | $835M | $576M | $631M | $754M | $793M | |
| Gross Profit Margin | 29.13% | 23.42% | 23.41% | 27.29% | 29.28% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $639M | $539M | $556M | $662M | $631M | |
| Other Inc / (Exp) | $46M | $177M | -$101M | $63M | -$47M | |
| Operating Expenses | $639M | $539M | $556M | $662M | $631M | |
| Operating Income | $196M | $37M | $75M | $92M | $162M | |
| Net Interest Expenses | -- | -- | -- | $10M | $30M | |
| EBT. Incl. Unusual Items | $242M | $214M | -$26M | $145M | $85M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $60M | $52M | -$1M | $35M | $13M | |
| Net Income to Company | $182M | $162M | -$25M | $110M | $72M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $182M | $162M | -$25M | $110M | $72M | |
| Basic EPS (Cont. Ops) | $2.12 | $1.88 | -$0.29 | $1.28 | $0.83 | |
| Diluted EPS (Cont. Ops) | $2.12 | $1.88 | -$0.29 | $1.28 | $0.82 | |
| Weighted Average Basic Share | $86M | $86M | $86M | $85.9M | $86.7M | |
| Weighted Average Diluted Share | $86M | $86M | $86M | $85.9M | $87.8M | |
| EBITDA | $265M | $282M | $42M | $221M | $193M | |
| EBIT | $196M | $214M | -$26M | $155M | $115M | |
| Revenue (Reported) | $2.9B | $2.5B | $2.7B | $2.8B | $2.7B | |
| Operating Income (Reported) | $196M | $37M | $75M | $92M | $162M | |
| Operating Income (Adjusted) | $196M | $214M | -$26M | $155M | $115M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $623M | $720M | $707M | $663M | |
| Revenue Growth (YoY) | -- | -- | 15.57% | -1.81% | -6.22% | |
| Cost of Revenues | -- | $500M | $540M | $504M | $474M | |
| Gross Profit | -- | $123M | $180M | $203M | $189M | |
| Gross Profit Margin | -- | 19.74% | 25% | 28.71% | 28.51% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $87M | $156M | $157M | $155M | |
| Other Inc / (Exp) | -- | $29M | $8M | $6M | -$9M | |
| Operating Expenses | -- | $87M | $156M | $157M | $155M | |
| Operating Income | -- | $36M | $24M | $46M | $34M | |
| Net Interest Expenses | -- | -- | -- | $8M | $3M | |
| EBT. Incl. Unusual Items | -- | $65M | $32M | $44M | $22M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $14M | $8M | $11M | $4M | |
| Net Income to Company | -- | $51M | $24M | $33M | $18M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $51M | $24M | $33M | $18M | |
| Basic EPS (Cont. Ops) | -- | $0.59 | $0.28 | $0.38 | $0.20 | |
| Diluted EPS (Cont. Ops) | -- | $0.59 | $0.28 | $0.37 | $0.20 | |
| Weighted Average Basic Share | -- | $86M | $86M | $86M | $86M | |
| Weighted Average Diluted Share | -- | $86M | $86M | $87M | $88M | |
| EBITDA | -- | $50M | $49M | $71M | $47M | |
| EBIT | -- | $36M | $32M | $52M | $25M | |
| Revenue (Reported) | -- | $623M | $720M | $707M | $663M | |
| Operating Income (Reported) | -- | $36M | $24M | $46M | $34M | |
| Operating Income (Adjusted) | -- | $36M | $32M | $52M | $25M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $2.8B | $2.8B | $2.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $2.1B | $2B | $1.9B | |
| Gross Profit | -- | -- | $688M | $776M | $779M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $625M | $664M | $629M | |
| Other Inc / (Exp) | -- | $29M | -$122M | $61M | -$62M | |
| Operating Expenses | -- | -- | $625M | $664M | $629M | |
| Operating Income | -- | -- | $63M | $112M | $150M | |
| Net Interest Expenses | -- | -- | -- | $18M | $25M | |
| EBT. Incl. Unusual Items | -- | -- | -$59M | $155M | $63M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$7M | $38M | $6M | |
| Net Income to Company | -- | -- | -$52M | $119M | $57M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$52M | $117M | $57M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.60 | $1.37 | $0.66 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.60 | $1.36 | $0.64 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | $41M | $241M | $169M | |
| EBIT | -- | -- | -$30M | $173M | $88M | |
| Revenue (Reported) | -- | -- | $2.8B | $2.8B | $2.7B | |
| Operating Income (Reported) | -- | -- | $63M | $112M | $150M | |
| Operating Income (Adjusted) | -- | -- | -$30M | $173M | $88M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $623M | $720M | $707M | $663M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $500M | $540M | $504M | $474M | |
| Gross Profit | -- | $123M | $180M | $203M | $189M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $87M | $156M | $157M | $155M | |
| Other Inc / (Exp) | -- | $29M | $8M | $6M | -$9M | |
| Operating Expenses | -- | $87M | $156M | $157M | $155M | |
| Operating Income | -- | $36M | $24M | $46M | $34M | |
| Net Interest Expenses | -- | -- | -- | $8M | $3M | |
| EBT. Incl. Unusual Items | -- | $65M | $32M | $44M | $22M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $14M | $8M | $11M | $4M | |
| Net Income to Company | -- | $51M | $24M | $33M | $18M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $51M | $24M | $33M | $18M | |
| Basic EPS (Cont. Ops) | -- | $0.59 | $0.28 | $0.38 | $0.20 | |
| Diluted EPS (Cont. Ops) | -- | $0.59 | $0.28 | $0.37 | $0.20 | |
| Weighted Average Basic Share | -- | $86M | $86M | $86M | $86M | |
| Weighted Average Diluted Share | -- | $86M | $86M | $87M | $88M | |
| EBITDA | -- | $50M | $49M | $71M | $47M | |
| EBIT | -- | $36M | $32M | $52M | $25M | |
| Revenue (Reported) | -- | $623M | $720M | $707M | $663M | |
| Operating Income (Reported) | -- | $36M | $24M | $46M | $34M | |
| Operating Income (Adjusted) | -- | $36M | $32M | $52M | $25M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $89M | $40M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $205M | $122M | $213M | $225M | $168M | |
| Inventory | $280M | $330M | $431M | $345M | $353M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $10M | $16M | $10M | $28M | $27M | |
| Total Current Assets | $505M | $501M | $670M | $706M | $619M | |
| Property Plant And Equipment | $635M | $627M | $645M | $757M | $899M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $53M | $53M | $53M | $53M | $53M | |
| Other Intangibles | $57M | $57M | $57M | $57M | $57M | |
| Other Long-Term Assets | $9M | $6M | $11M | $33M | $33M | |
| Total Assets | $1.3B | $1.2B | $1.4B | $1.9B | $2B | |
| Accounts Payable | $447M | $373M | $473M | $541M | $513M | |
| Accrued Expenses | $169M | $173M | $135M | $178M | $159M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $8M | $24M | |
| Current Portion Of Capital Lease Obligations | -- | $3M | -- | $6M | $18M | |
| Other Current Liabilities | $33M | -- | $47M | $92M | $62M | |
| Total Current Liabilities | $664M | $560M | $666M | $836M | $841M | |
| Long-Term Debt | -- | -- | -- | $487M | $460M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $765M | $674M | $749M | $1.6B | $1.6B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -$38M | -$37M | -$38M | -$28M | -$42M | |
| Common Equity | $494M | $570M | $687M | $300M | $317M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $494M | $570M | $687M | $300M | $317M | |
| Total Liabilities and Equity | $1.3B | $1.2B | $1.4B | $1.9B | $2B | |
| Cash and Short Terms | -- | -- | -- | $89M | $40M | |
| Total Debt | -- | -- | -- | $499M | $535M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $70M | $27M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $219M | $223M | $185M | |
| Inventory | -- | -- | $374M | $328M | $371M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | $9M | $22M | $23M | |
| Total Current Assets | -- | -- | $602M | $664M | $652M | |
| Property Plant And Equipment | -- | -- | $711M | $735M | $919M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | $53M | $53M | $53M | |
| Other Intangibles | -- | -- | $57M | $57M | $57M | |
| Other Long-Term Assets | -- | -- | $9M | $87M | $27M | |
| Total Assets | -- | -- | $1.4B | $1.9B | $2B | |
| Accounts Payable | -- | -- | $439M | $544M | $527M | |
| Accrued Expenses | -- | -- | $128M | $196M | $120M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $8M | $26M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $10M | $21M | |
| Other Current Liabilities | -- | -- | $44M | $17M | $56M | |
| Total Current Liabilities | -- | -- | $624M | $789M | $836M | |
| Long-Term Debt | -- | -- | -- | $484M | $502M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $816M | $1.6B | $1.7B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -$49M | -$32M | -$45M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $616M | $317M | $327M | |
| Total Liabilities and Equity | -- | -- | $1.4B | $1.9B | $2B | |
| Cash and Short Terms | -- | -- | -- | $70M | $27M | |
| Total Debt | -- | -- | -- | $494M | $597M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $182M | $162M | -$25M | $110M | $72M | |
| Depreciation & Amoritzation | $69M | $68M | $68M | $66M | $78M | |
| Stock-Based Compensation | $2M | $2M | $3M | $8M | $16M | |
| Change in Accounts Receivable | $25M | $61M | -$74M | -$85M | $55M | |
| Change in Inventories | $22M | -$50M | -$102M | $86M | -$12M | |
| Cash From Operations | $303M | $7M | $53M | $422M | $100M | |
| Capital Expenditures | $87M | $75M | $71M | $150M | $129M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$87M | -$75M | -$71M | -$146M | -$129M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$677M | -$55M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $668M | $77M | |
| Long-Term Debt Repaid | -- | -- | -- | -$164M | -$43M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$216M | $68M | $18M | -$15M | -- | |
| Cash From Financing | -$216M | $68M | $18M | -$188M | -$16M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $89M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $88M | -$45M | |
| Ending Cash (CF) | -- | -- | -- | $89M | $40M | |
| Levered Free Cash Flow | $216M | -$68M | -$18M | $272M | -$29M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $51M | $24M | $33M | $18M | |
| Depreciation & Amoritzation | -- | $14M | $17M | $19M | $22M | |
| Stock-Based Compensation | -- | $1M | $1M | $1M | $5M | |
| Change in Accounts Receivable | -- | -$63M | $7M | $2M | -$17M | |
| Change in Inventories | -- | -$16M | $57M | $16M | -$18M | |
| Cash From Operations | -- | $2M | $62M | $10M | -$2M | |
| Capital Expenditures | -- | $10M | $31M | $9M | $60M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$10M | -$31M | -$9M | -$60M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$14M | -$14M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $144M | |
| Long-Term Debt Repaid | -- | -- | -- | -$6M | -$82M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $8M | -$30M | -- | -- | |
| Cash From Financing | -- | $8M | -$30M | -$19M | $49M | |
| Beginning Cash (CF) | -- | -- | -- | $88M | $40M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $1M | -$18M | -$13M | |
| Ending Cash (CF) | -- | -- | $1M | $70M | $27M | |
| Levered Free Cash Flow | -- | -$8M | $31M | $1M | -$62M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$52M | $119M | $57M | |
| Depreciation & Amoritzation | -- | -- | $71M | $68M | $81M | |
| Stock-Based Compensation | -- | $1M | $3M | $8M | $20M | |
| Change in Accounts Receivable | -- | -- | -$4M | -$90M | $36M | |
| Change in Inventories | -- | -- | -$29M | $45M | -$46M | |
| Cash From Operations | -- | -- | $113M | $370M | $88M | |
| Capital Expenditures | -- | $10M | $92M | $128M | $180M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$92M | -$124M | -$180M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$691M | -$55M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$170M | -$119M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$20M | -- | -- | |
| Cash From Financing | -- | -- | -$20M | -$177M | $52M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $69M | -$40M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | $21M | $242M | -$92M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $51M | $24M | $33M | $18M | |
| Depreciation & Amoritzation | -- | $14M | $17M | $19M | $22M | |
| Stock-Based Compensation | -- | $1M | $1M | $1M | $5M | |
| Change in Accounts Receivable | -- | -$63M | $7M | $2M | -$17M | |
| Change in Inventories | -- | -$16M | $57M | $16M | -$18M | |
| Cash From Operations | -- | $2M | $62M | $10M | -$2M | |
| Capital Expenditures | -- | $10M | $31M | $9M | $60M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$10M | -$31M | -$9M | -$60M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$14M | -$14M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $144M | |
| Long-Term Debt Repaid | -- | -- | -- | -$6M | -$82M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $8M | -$30M | -- | -- | |
| Cash From Financing | -- | $8M | -$30M | -$19M | $49M | |
| Beginning Cash (CF) | -- | -- | -- | $88M | $40M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $1M | -$18M | -$13M | |
| Ending Cash (CF) | -- | -- | $1M | $70M | $27M | |
| Levered Free Cash Flow | -- | -$8M | $31M | $1M | -$62M | |
Get KLG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
KLG
Sector
P/E ratio
36.22x
18.49x
PEG ratio
--
0.21x
P/B ratio
6.11x
1.62x
Price / LTM sales
0.76x
0.60x
Growth Metrics
KLG
Sector
Revenue growth
-6.22%
-0.93%
Earnings growth
-45.95%
--
Revenue (5-year growth)
--
3.8%
Earnings forecast
$0.27
$0.34
Profitability
KLG
Sector
Profitability FY 2024
$793M
$513.8M
Return on invested capital
6.76%
5.19%
Return on assets
2.95%
3.41%
Return on equity
17.67%
7.97%
Earnings Date
Last Earnings Date
May
6
Next Earnings Date
Aug
6
Estimated Next Earnings Date
Aug
5
Balance Sheet
KLG
Sector
Total cash
$27M
$122.2M
Short term investments
--
$39.3M
Total assets
$2B
$1.6B
Long term debt
$597M
$193.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
